CXCR4 expression enhances diffuse large B cell lymphoma dissemination and decreases patient survival-Reference-Cited by-同舟云学术

CXCR4 expression enhances diffuse large B cell lymphoma dissemination and decreases patient survival

Published:2014-12-11 Issue:3 Volume:235 Page:445-455
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Moreno María José¹²³,Bosch Rosa⁴,Dieguez-Gonzalez Rebeca¹,Novelli Silvana⁴,Mozos Ana⁵,Gallardo Alberto⁶,Pavón Miguel Ángel¹³,Céspedes María Virtudes¹³,Grañena Albert⁷,Alcoceba Miguel⁸,Blanco Oscar⁸,Gonzalez-Díaz Marcos⁸,Sierra Jorge⁴,Mangues Ramon¹³,Casanova Isolda¹³

Affiliation:

1. Grup d'Oncogènesi i Antitumorals; lnstitut d'Investigacions Biomèdiques Sant Pau; Barcelona Spain

2. Department of Biochemistry and Molecular Biology; Universitat de Barcelona; Spain

3. CIBER en Bioingeniería, Biomateriales y Nanomecidicina (CIBER-BBN); Barcelona Spain

4. Department of Haematology; Hospital de la Santa Creu i Sant Pau; Barcelona Spain

5. Department of Pathology; Hospital de la Santa Creu i Sant Pau; Barcelona Spain

6. Department of Pathology, Clínica Girona; Girona Spain

7. Department of Haematology; Hospital Universitari de Bellvitge; Barcelona Spain

8. Department of Haematology and Pathology; IBSAL-University Hospital, Centre for Cancer Research-IBMCC (USAL-CSIC); Salamanca Spain

Funder

AGAUR

CIBER BBN

FundaciÃ³ Cellex

FundaciÃ³ InvestigaciÃ³ Sant Pau

FundaciÃ³ La MaratÃ³ TV3

Health Council of Castilla y Leon

Insituto de Salud Carlos III

Instituto de Salud Carlos III

Josep Carreras Leukaemia Research Institute

MICINN

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Reference49 articles.

1. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte;Feugier;J Clin Oncol,2005

2. CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group;Pfreundschuh;Lancet Oncol,2011

3. Ten years follow-up of the GELA LNH98.5 study, first randomized study comparing R-CHOP to CHOP chemotherapy in patients with diffuse large B-cell lymphoma;Coiffier;Blood (ASH Annu Meet Abstr),2009

4. Diffuse large B-cell lymphoma: current strategies and future directions;Cultrera;Cancer Control,2012

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of unique B-cell populations in the circulation of people living with HIV prior to non-Hodgkin lymphoma diagnosis;Frontiers in Immunology;2024-09-11

2. Applying Molecular Modeling to the Design of Innovative, Non-Symmetrical CXCR4 Inhibitors with Potent Anticancer Activity;International Journal of Molecular Sciences;2024-08-30

3. Recent advances in CD5+ diffuse large B-cell lymphoma;Annals of Hematology;2024-08-28

4. Investigational CXCR4 inhibitors in early phase development for the treatment of hematological malignancies;Expert Opinion on Investigational Drugs;2024-08-08

5. Indicators describing the tumor lesion aggregation and dissemination and their impact on the prognosis of patients with diffuse large B cell lymphoma receiving chimeric antigen receptor T cell therapy;Cancer Medicine;2024-03